Bronwyn Evans Bought 54% More Shares In EBR Systems - simplywall.st
Bronwyn Evans Bought 54% More Shares In EBR Systems simplywall.st
Latest articles and price-sensitive announcements with AI sentiment classification.
Bronwyn Evans Bought 54% More Shares In EBR Systems simplywall.st
ASX: EBR — EBR Systems Raises the Bar as Medtech Capital Markets Stay Tough Kalkine
other announcement
capital_raise announcement

EBR Systems' $150 million cap raising takes the 12-month sectoral tally to almost $1.5 billion – but issuers aren't having ... Read More The post Biocurious: EBR Systems raises the bar in a sluggish capital raising climate appeared first on Stockhead.

Host Tylah Tully sits down with EBR Systems CEO and President John McCutcheon to discuss the company's fully underwritten $150 ... Read More The post Long Shortz with EBR: $150m cap raise marks significant milestone on path to profitability appeared first on Stockhead.
EBR Systems (ASX:EBR) Launches $150m Capital Raise, Shares Stumble Kalkine

EBR launches $150 million capital raise to support US commercial expansion of its groundbreaking WISE heart device. ... Read More The post EBR raises $150 million to turbocharge its US heart device rollout appeared first on Stockhead.
EBR Systems (ASX:EBR) lands CMS gate with March 2027 Medicare date Stocks Down Under
other announcement
other announcement
EBR Systems (ASX:EBR) Jumps Nearly 10% as Healthcare Stocks Defy Broader Market Weakness Kalkine

EBR more than doubled commercial WiSE implants during Q1 2026 as the company expanded its US limited market release rollout ... Read More The post EBR powers ahead as WiSE commercial implants double in Q1 2026 appeared first on Stockhead.
other announcement
other announcement

Fast-track process could bring earlier access to leadless CRT for heart failure patients with limited options ... Read More The post EBR closer to entering Australian market after TGA fast-tracks WiSE CRT system appeared first on Stockhead.
other announcement

Highlights Faster regulatory pathway clears review timeline Wireless cardiac device reshapes treatment approach Focus on unmet needs in heart failure care EBR Systems (EBR) advances toward regulatory approval in Australia after securing a priority review, highlighting progress in wireless cardiac therapy and improving access to innovative treatment options. The Australian healthcare space continues to evolve, and ASX healthcare stock (ASX:EBR) has recently drawn notable attention follow...
other announcement
director_dealing announcement

Total implants for WiSE across the pilot phase and limited market release now stands at 71. ... Read More The post EBR doubles WiSE CRT cases as momentum builds appeared first on Stockhead.
other announcement
other announcement
other announcement
MoneyTalks: Why Bell Potter thinks EBR shares could triple Stockhead

These shares are avoiding the market selloff. The post Why EBR, EOS, Racura, and Woodside shares are rising today appeared first on The Motley Fool Australia.
other announcement